PLoS ONE (Jan 2012)

Antibody constant region peptides can display immunomodulatory activity through activation of the Dectin-1 signalling pathway.

  • Elena Gabrielli,
  • Eva Pericolini,
  • Elio Cenci,
  • Claudia Monari,
  • Walter Magliani,
  • Tecla Ciociola,
  • Stefania Conti,
  • Rita Gatti,
  • Francesco Bistoni,
  • Luciano Polonelli,
  • Anna Vecchiarelli

DOI
https://doi.org/10.1371/journal.pone.0043972
Journal volume & issue
Vol. 7, no. 8
p. e43972

Abstract

Read online

We previously reported that a synthetic peptide with sequence identical to a CDR of a mouse monoclonal antibody specific for difucosyl human blood group A exerted an immunomodulatory activity on murine macrophages. It was therapeutic against systemic candidiasis without possessing direct candidacidal properties. Here we demonstrate that a selected peptide, N10K, putatively deriving from the enzymatic cleavage of the constant region (Fc) of human IgG(1), is able to induce IL-6 secretion and pIkB-α activation. More importantly, it causes an up-regulation of Dectin-1 expression. This leads to an increased activation of β-glucan-induced pSyk, CARD9 and pIkB-α, and an increase in the production of pro-inflammatory cytokines such as IL-6, IL-12, IL-1β and TNF-α. The increased activation of this pathway coincides with an augmented phagocytosis of non opsonized Candida albicans cells by monocytes. The findings suggest that some Fc-peptides, potentially deriving from the proteolysis of immunoglobulins, may cause an unexpected immunoregulation in a way reminiscent of innate immunity molecules.